IL17A and Fabry disease: Probiotic therapy may be beneficial for immunomodulation and microbial regulation in FD as patients taking spore-forming probiotics more frequently achieved clinical endpoints with decreased pro-inflammatory IL-17 and Th17 cytokines and increased concentrations of Faecalibacterium and Roseburia in stools (Wauters et al., 2021c).